Sulpiride adjunction to clozapine in treatment-resistant schizophrenic patients: A preliminary case series study

European Psychiatry

Volumn 12, Issue 3, 1997, Pages 152-155

  Shiloh, R ^a,b   Zemishlany, Z ^a,b   Aizenberg, D ^a,b   Weizman, A ^a,b  

^a GEHA MENTAL HEALTH CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

clozapine; dopamine; prolactin; schizophrenia; sulpiride

Indexed keywords

CLOZAPINE; SULPIRIDE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

EID: 0030946095     PISSN: 09249338     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-9338(97)80205-2     Document Type: Article

References (20)

1. Andreasen NC. Scale for the Assessment of Negative Symptoms (SANS). Iowa City: The University of Iowa, 1983
2. Andreasen NC. Scale for the Assessment of Positive Symptoms (SANS). Iowa City: The University of Iowa, 1984
3. Casey DE, Gerlach J. Sulpiride in tardive dyskinesia. Psychopharmacology (Berlin) 1979;66:73-7
4. Cassano GB, Castrogiovanni P, Conti L. Sulpiride versus haloperidol in schizophrenia: a double-blind comparative trial. Curr Ther Res 1975;17:189-201
5. Edwards JG, Alexander JR, Alexander MS, Gordon A, Zutchi T. Controlled trial of sulpiride in chronic schizophrenic patients. Br J Psychiatry 1980;137:522-9
6. Farmer AE, Blewett A. Drug treatment of resistant schizophrenia. Drugs 1993;45:374-83
7. Gudelsky GA, Nash JF, Berry SA. Basic biology of clozapine. Electrophysiological and neuroendocrinological studies. Psychopharmacology (Berlin) 1989;99:513-7
8. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
9. Harnryd C, Bjerkenstedt L, Bjork K, Gullbers B, Oxenstierna G, Sedvall G, Wiesel FA, Wik G, Aberg-Wistedt A. Clinical evaluation of sulpiride in schizophrenic patients - A double-blind comparison with chlorpromazine. Acta Psychiatr Scand 1984;69 (suppl 311):7-30
10. Kane J. Clinical efficacy of clozapine in treatment of refractory schizophrenia: an overview. Br J Psychiatry 1992;18 (suppl 17):41-5
11. Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment of resistant schizophrenia. Arch Gen Psychiatry 1988;45:789-96
12. Lieberman J, Saltz B, Johns C, Pollak S, Borentein M, Kane J. The effects of clozapine on tardive dyskinesia. Br J Psychiatry 1991;158:503
13. Mielke DH, Gallant DM, Roniger JJ, Kessler C, Kessler LR. Sulpiride: evaluation of antipsychotic activity in schizophrenic patients. J Nerv Ment Dis 1977;38:569-71
14. Moriuchi K, Imazu Y, Yoneda H. Differences in effects of sultopride and sulpiride on dopamine turnover in rat brain. Neurochem Res 1995;20:95-9
15. Nishiura M. Clinico-pharmacological studies of sulpiride. Curr Ther Res 1976;20:164-72
16. Niskanen P, Tamminen T, Viukari M. Sulpiride versus amitryptyline in the treatment of depression. Curr Ther Res 1975;17:281
17. Overall JE, Gorham DE. The brief psychiatric rating scale. Psy-chol Rep 1961;10:799-812
18. Pickar D, Owen RR, Litman RE, Hisiao JK, Su TP. Predictors of clozapine response in schizophrenia. J Clin Psychiatry 1994;55:129-32
19. Pucak ML, Grace AA. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors. J Pharmacol Exp Ther 1994;271:1181-92
20. Tamminga CA, Gerlach J. New neuroleptics and experimental anti psychotics in schizophrenia. In: Meltzer HY, ed. Psychopharmacology, the Third Generation of Progress. New York: Raven Press, 1987;1130-2